Skip to main content
Clinical Trials/JPRN-jRCTs052220038
JPRN-jRCTs052220038
Recruiting
未知

Efficacy and Safety of Cryoballoon Ablation in Asymptomatic Patients with Atrial Fibrillation (ASYM study)

Miyamoto Koji0 sites60 target enrollmentJune 6, 2022

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
Miyamoto Koji
Enrollment
60
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
June 6, 2022
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Miyamoto Koji

Eligibility Criteria

Inclusion Criteria

  • 1\. Patients aged 20\-85 years old
  • 2\. Patients who atrial fibrillation was documented with 12\-lead EGC within a year
  • 3\. Patients diagnosed as asymptomatic atrial fibrillation
  • 4\. Patients with written informed consent

Exclusion Criteria

  • 1\. Patients with history of catheter ablation and/or surgery of atrial fibrillation
  • 2\. Patients with left atrial dimension more than 55 mm
  • 3\. Pregnant patients
  • 4\. Patients with concomittant participation in intervention study with other medication and/or medical instrument
  • 5\. Patients with active systemic infection
  • 6\. Patients with thrombus in the heart
  • 7\. Patients with cryoglobulinemia
  • 8\. Patients after stent implantation at pulmonary veins
  • 9\. Patients with LVEF \<35%
  • 10\. Patients with heart failure of NYHA III or iV

Outcomes

Primary Outcomes

Not specified

Similar Trials